981 related articles for article (PubMed ID: 28264426)
1. The Combination of Blueberry Juice and Probiotics Ameliorate Non-Alcoholic Steatohepatitis (NASH) by Affecting SREBP-1c/PNPLA-3 Pathway via PPAR-α.
Ren T; Zhu J; Zhu L; Cheng M
Nutrients; 2017 Feb; 9(3):. PubMed ID: 28264426
[TBL] [Abstract][Full Text] [Related]
2. The combination of blueberry juice and probiotics reduces apoptosis of alcoholic fatty liver of mice by affecting SIRT1 pathway.
Zhu J; Ren T; Zhou M; Cheng M
Drug Des Devel Ther; 2016; 10():1649-61. PubMed ID: 27274198
[TBL] [Abstract][Full Text] [Related]
3. Preventive effect of trans-chalcone on non-alcoholic steatohepatitis: Improvement of hepatic lipid metabolism.
Karimi-Sales E; Ebrahimi-Kalan A; Alipour MR
Biomed Pharmacother; 2019 Jan; 109():1306-1312. PubMed ID: 30551380
[TBL] [Abstract][Full Text] [Related]
4. Amelioration by chicory seed extract of diabetes- and oleic acid-induced non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) via modulation of PPARα and SREBP-1.
Ziamajidi N; Khaghani S; Hassanzadeh G; Vardasbi S; Ahmadian S; Nowrouzi A; Ghaffari SM; Abdirad A
Food Chem Toxicol; 2013 Aug; 58():198-209. PubMed ID: 23603006
[TBL] [Abstract][Full Text] [Related]
5. Aqueous Extract of Pepino (
Hsu JY; Lin HH; Hsu CC; Chen BC; Chen JH
Nutrients; 2018 Jul; 10(7):. PubMed ID: 30037014
[TBL] [Abstract][Full Text] [Related]
6. Involvement of hepatic peroxisome proliferator-activated receptor α/γ in the therapeutic effect of osthole on high-fat and high-sucrose-induced steatohepatitis in rats.
Zhao X; Xue J; Wang XL; Zhang Y; Deng M; Xie ML
Int Immunopharmacol; 2014 Sep; 22(1):176-81. PubMed ID: 24993341
[TBL] [Abstract][Full Text] [Related]
7. Overproduction of altered VLDL in an insulin-resistance rat model: Influence of SREBP-1c and PPAR-α.
Lucero D; Miksztowicz V; Macri V; López GH; Friedman S; Berg G; Zago V; Schreier L
Clin Investig Arterioscler; 2015; 27(4):167-74. PubMed ID: 25796423
[TBL] [Abstract][Full Text] [Related]
8. Thyrotropin increases hepatic triglyceride content through upregulation of SREBP-1c activity.
Yan F; Wang Q; Lu M; Chen W; Song Y; Jing F; Guan Y; Wang L; Lin Y; Bo T; Zhang J; Wang T; Xin W; Yu C; Guan Q; Zhou X; Gao L; Xu C; Zhao J
J Hepatol; 2014 Dec; 61(6):1358-64. PubMed ID: 25016220
[TBL] [Abstract][Full Text] [Related]
9. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
[TBL] [Abstract][Full Text] [Related]
10. Effect of Dangfei Liganning capsule on liver X receptor α/steroid regulatory element binding protein-1/fatty acid synthase signal pathway in rats with metabolic- associated fatty liver disease.
Xiaoling LI; Fengxia S; Zimeng S; Yingxue Z; Jie LI; Qiuxiang Z
J Tradit Chin Med; 2022 Dec; 42(6):940-947. PubMed ID: 36378052
[TBL] [Abstract][Full Text] [Related]
11. Rotundic acid ameliorates non-alcoholic steatohepatitis via SREBP-1c/ SCD1 signaling pathway and modulating gut microbiota.
Liu HJ; Cao ST; Wen BY; Han X; Li Y; Li S; Li J; Zhang L
Int Immunopharmacol; 2021 Oct; 99():108065. PubMed ID: 34426119
[TBL] [Abstract][Full Text] [Related]
12. Betanin effect on PPAR-α and SREBP-1c expression in NMRI mice model of steatohepatitis with fibrosis.
Yahaghi L; Yaghmaei P; Hayati-Roodbari N; Irani S; Ebrahim-Habibi A
Physiol Int; 2020 Mar; 107(1):67-81. PubMed ID: 32491288
[TBL] [Abstract][Full Text] [Related]
13. Effects of combined PPAR-γ and PPAR-α agonist therapy on fructose induced NASH in rats: Modulation of gene expression.
Abd El-Haleim EA; Bahgat AK; Saleh S
Eur J Pharmacol; 2016 Feb; 773():59-70. PubMed ID: 26825546
[TBL] [Abstract][Full Text] [Related]
14. Biochemical and histological characterisation of an experimental rodent model of non-alcoholic steatohepatitis - Effects of a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a glucagon-like peptide-1 analogue.
Daniels SJ; Leeming DJ; Detlefsen S; Bruun MF; Hjuler ST; Henriksen K; Hein P; Karsdal MA; Brockbank S; Cruwys S
Biomed Pharmacother; 2019 Mar; 111():926-933. PubMed ID: 30841472
[TBL] [Abstract][Full Text] [Related]
15. Protective Effect of Glycyrrhizic Acid on Alcoholic Liver Injury in Rats by Modulating Lipid Metabolism.
Huo X; Yang S; Sun X; Meng X; Zhao Y
Molecules; 2018 Jul; 23(7):. PubMed ID: 29973492
[TBL] [Abstract][Full Text] [Related]
16. [Role and mechanism of action of fibroblast growth factor-21 in reducing triglyceride in nonalcoholic fatty liver disease].
Chen L; Jiang M; Xin Y; Wang J; Liu Y; Jiang X; Xuan S
Zhonghua Gan Zang Bing Za Zhi; 2016 Feb; 24(2):102-7. PubMed ID: 26983476
[TBL] [Abstract][Full Text] [Related]
17. Effects of Danhong injection on dyslipidemia and cholesterol metabolism in high-fat diets fed rats.
Du H; Li C; Wang Z; He Y; Wang Y; Zhou H; Wan H; Yang J
J Ethnopharmacol; 2021 Jun; 274():114058. PubMed ID: 33766756
[TBL] [Abstract][Full Text] [Related]
18. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
19. Pioglitazone ameliorates nonalcoholic steatohepatitis by down-regulating hepatic nuclear factor-kappa B and cyclooxygenases-2 expression in rats.
Zhao JS; Zhu FS; Liu S; Yang CQ; Chen XM
Chin Med J (Engl); 2012 Jul; 125(13):2316-21. PubMed ID: 22882855
[TBL] [Abstract][Full Text] [Related]
20. [The Effect of p-JAK1/p-STAT3 Signaling Way in Intervening NAFLD by Blueberry Probiotic Serum].
Zhu JJ; Cheng ML; Zhou MY; Zhao XK
Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Mar; 48(2):203-209. PubMed ID: 28612527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
